Table 1 Demographics and clinical characteristics of participants from Central Australia according to HTLV-1c status
From: High level of genomic divergence in orf-I p12 and hbz genes of HTLV-1 subtype-C in Central Australia
HTLV-1c– (n = 15) | HTLV-1c +  (n = 22) | p-value | |
|---|---|---|---|
Demographics, n (%) | |||
Median age | 40.0 | 49.5 | 0.15 |
Female at birth | 7/15 (46.7%) | 13/22 (59.1%) | 0.52 |
Male at birth | 8/15 (53.3%) | 9/22(40.1%) | |
Lifestyle, n (%) | |||
Smoker (current or previous) | 8/15 (53.3%) | 9/15 (60.0%)Ø |  > 0.99 |
Harmful alcohol consumption | 9/15 (60.0%) | 9/17 (52.9%)Ø | 0.73 |
Comorbidities, n (%) | |||
Asthma | 2/15 (13.3%) | 2/22 (9.1%) |  > 0.99 |
Ischaemic heart disease | 2/15 (13.3%) | 4/22 (18.2%) |  > 0.99 |
Diabetes | 6/15 (40.0%) | 11/22 (50%) | 0.72 |
Chronic liver disease (CLD) | 0/15 (0%) | 3/22 (13.6%) | 0.26 |
Chronic kidney disease (CKD) | 7/15 (46.7%) | 13/22 (59.1%) | 0.52 |
Hepatitis B Virus (HbsAg) | 0/9 (0%)Ø | 2/20 (10.0%)Ø |  > 0.99 |
Potential HTLV-1 associated diseases, n (%) | |||
Pulmonary Disease | 5/15 (33.3%) | 9/22 (40.1%) | 0.74 |
Strongyloidiasis, current | 2/15 (13.3%) | 2/21 (9.5%)Ø |  > 0.99 |
Blood stream infection (BSI) | 0/15 (0%) | 10/22 (45.5%) | 0.002** |
HTLV-1 associated myelopathy (HAM) | 0/15 (0%) | 0/22 (0%) |  > 0.99 |
Adult T cell leukemia/lymphoma (ATL) | 0/15 (0%) | 0/22 (0%) |  > 0.99 |